84891-1
Tumor response to neoadjuvant therapy
Active
Term Description
The response of the tumor to neoadjuvant treatment, such as chemotherapy and radiotherapy. Chemotherapy and/or radiotherapy before resection is associated with significant downstaging and improved prognosis. These specimens require close gross examination and additional blocking to demonstrate tumor. The degree of tumor regression has been shown to correlate with prognosis. This term was created for, but not limited in use to, the Colorectal Cancer Structured Reporting Protocol (2nd Edition, 2012) developed by the Royal College of Pathologists of Australasia (RCPA).
LOINC Names Get Info
- Fully-Specified Name
- Response to neoadjuvant therapy:
PrThr: Pt: Colorectal cancer specimen: Ord: - Long Common Name
- Tumor response to neoadjuvant therapy
- Short Name
- Tumor resp to neoadjvt therapy
- Display Name
- Response to neoadjuvant therapy Ql (Colorectal cancer specimen)
- Consumer Name Alpha Get Info
- Response to neoadjuvant therapy, Colorectal cancer specimen
Part Model Get Info
- Component
- Response to neoadjuvant therapy
LP222094-7
- Analyte
- Response to neoadjuvant therapy
LP222094-7
- Component Numerator
- Response to neoadjuvant therapy
LP222094-7
- Component Numerator Core
- Response to neoadjuvant therapy
LP222094-7
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- PrThr
LP217195-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Colorectal cancer specimen
LP222067-3
- System Core
- Colorectal cancer specimen
LP222067-3
- Super System
- NULL
- Scale
- Ord
LP7751-3
- Method
- NULL
Example Answer List: LL4077-5
Source: The Royal College of Pathologists of Australasia| Answer | Code | Score | Answer ID |
|---|---|---|---|
| No prior treatment | LA26537-3 | ||
| Complete response (Grade 0 - No viable cancer cells) | LA26538-1 | ||
| Moderate response (Grade 1 - Single cells or small groups of cancer cells) | LA26539-9 | ||
| Mminimal response (Grade 2 - Residual cancer outgrown by fibrosis) | LA26540-7 | ||
| Poor response (Grade 3 - Minimal or no tumor kill; extensive) | LA26541-5 |
Basic Attributes
- Class
- PATH
- Type
- Laboratory
- First Released
- Version 2.58
- Last Updated
- Version 2.71 (MIN)
- Change Reason
- This term is still in Trial status and upon further review, the System was updated from 'Specimen' to reflect that this concept is specific to the colorectal cancer reporting protocol.
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 85905-8 | Cancer pathology panel - Colorectal cancer specimen by CAP cancer protocols |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Neoadjuvantní terapie odpověď: |
| el-GR | Greek (Greece) | Ανταπόκριση στη νεοεπικουρική θεραπεία: Synonyms: Ord PATH PrThr Pt Ανταπόκριση στη νεοεπικουρική θεραπεία Δείγμα Δείγμα καρκίνου Δείγμα καρκίνου του παχέος εντέρου Καρκίνος |
| es-ES | Spanish (Spain) | Respuesta a la terapia neoadyuvante: |
| es-MX | Spanish (Mexico) | Respuesta a la terapia neoadyuvante: |
| it-IT | Italian (Italy) | Risposta a terapia neoadiuvante: Synonyms: Campione di tumore Neoplasia maligna Patologia Presenza o Soglia Punto nel tempo (episodio) |
| zh-CN | Chinese (China) | 对新辅助疗法的反应: Synonyms: 供检查用的材料; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://